Biotech & AI drug discoverySTAT — Biotech

STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early

As reported by STAT+, highly anticipated data for the Moderna-Merck personalized mRNA melanoma cancer vaccine were released early at ESMO. Per the supplied context, the released data concerned recurrence-free survival and the time until distant metastasis occurred.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-23T19:19:55+00:00

Published here2026-10-23T23:15:39+00:00

Original source

STAT — Biotech

Media report · consult original reporting

Read the original ↗https://www.statnews.com/2026/10/23/moderna-merck-melanoma-cancer-vaccine-data-arrived-early-esmo/

Original headline

STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.